Furthermore, even though reduced bone mass was found in young subjects with moderate type 1 diabetes with metabolic control [32], the findings in the present study are related to severe diabetes (i.e., BG ≥ 300 mg/dL), thus, it is difficult to generalize to patients treated with insulin. Here, INS is linked to diabetes mellitus.